Shopping Cart 0
Cart Subtotal

GNA Biosolutions GmbH - Product Pipeline Analysis, 2018 Update

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 750

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 1500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 2250
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies



GNA Biosolutions GmbH (GNAB) is an assays and instruments development company that develops assays and instruments for ultra-fast molecular pathogen detection of biomolecules through its technology. The company also develops rapid diagnostic DNA-based laser-heated nanoparticles. It uses PCR (Polymerase Chain Reaction) ultra-fast laser heating technology of nanoparticles detects pathogens. GNAB's heating and cooling ramps lead to the ultra-fast DNA amplification. The company's products find applications in medical diagnostics, biosecurity, food safety and infrastructure surveillance, among others. Its nanostove detection develops instruments and regents based on rapid DNA analysis. GNAB is headquartered in Munich, Germany.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.


- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company GNA Biosolutions GmbH

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company


Table Of Content


Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

GNA Biosolutions GmbH Company Overview 4

GNA Biosolutions GmbH Company Snapshot 4

GNA Biosolutions GmbH Pipeline Products and Ongoing Clinical Trials Overview 4

GNA Biosolutions GmbH-Pipeline Analysis Overview 6

GNA Biosolutions GmbH-Key Facts 6

GNA Biosolutions GmbH-Major Products and Services 7

GNA Biosolutions GmbH Pipeline Products by Development Stage 8

GNA Biosolutions GmbH Pipeline Products Overview 10

Antibiotic Resistance Panel 10

Antibiotic Resistance Panel Product Overview 10

Diagnostic Assay -Infectious Disease 11

Diagnostic Assay -Infectious Disease Product Overview 11

FILODIAG Ultra-fast Detection System 12

FILODIAG Ultra-fast Detection System Product Overview 12


KAREL Product Overview 13

Pharos400 System 14

Pharos400 System Product Overview 14

PITBUL Ultrafast TB Test 15

PITBUL Ultrafast TB Test Product Overview 15

SAGE Ultrafast Antibiotic Resistance Test 16

SAGE Ultrafast Antibiotic Resistance Test Product Overview 16

GNA Biosolutions GmbH-Key Competitors 17

GNA Biosolutions GmbH-Key Employees 18

GNA Biosolutions GmbH-Locations And Subsidiaries 19

Head Office 19

Recent Developments 20

GNA Biosolutions GmbH, Recent Developments 20

Apr 09, 2018: GNA Biosolutions to Showcase PCA Technology for Ultrafast PCR and Pharos V8 instrument at Analytica 2018 20

Mar 24, 2018: Multidisciplinary Consortium Announces Launch of PITBUL, an International Collaboration for the Development of Ultrafast Tuberculosis Diagnostics 20

Nov 14, 2017: GNA Biosolutions reveals new ultrafast PCR platform at Medica 21

Appendix 22

Methodology 22

About GlobalData 25

Contact Us 25

Disclaimer 25

List Of Figure

List of Figures

GNA Biosolutions GmbH Pipeline Products by Equipment Type 5

GNA Biosolutions GmbH Pipeline Products by Development Stage 8

List Of Table

List of Tables

GNA Biosolutions GmbH Pipeline Products and Ongoing Clinical Trials Overview 4

GNA Biosolutions GmbH Pipeline Products by Equipment Type 5

GNA Biosolutions GmbH Pipeline Products by Indication 5

GNA Biosolutions GmbH, Key Facts 6

GNA Biosolutions GmbH, Major Products and Services 7

GNA Biosolutions GmbH Number of Pipeline Products by Development Stage 8

GNA Biosolutions GmbH Pipeline Products Summary by Development Stage 9

Antibiotic Resistance Panel-Product Status 10

Antibiotic Resistance Panel-Product Description 10

Diagnostic Assay -Infectious Disease-Product Status 11

Diagnostic Assay -Infectious Disease-Product Description 11

FILODIAG Ultra-fast Detection System-Product Status 12

FILODIAG Ultra-fast Detection System-Product Description 12

KAREL-Product Status 13

KAREL-Product Description 13

Pharos400 System-Product Status 14

Pharos400 System-Product Description 14

PITBUL Ultrafast TB Test-Product Status 15

PITBUL Ultrafast TB Test-Product Description 15

SAGE Ultrafast Antibiotic Resistance Test-Product Status 16

SAGE Ultrafast Antibiotic Resistance Test-Product Description 16

GNA Biosolutions GmbH, Key Employees 18

Glossary 24

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to

Products and Companies


GNA Biosolutions GmbH, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies


Miltenyi Biotec GmbH

CellGenix GmbH

Biomeva GmbH